Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

Sana Biotechnology Inc.'s stock soared over 200% on Wednesday, on track to mark its best day on record, amid trading volumes spiking to 54 times the daily average. The surge followed highly positive ...

She won two Gold Telly Awards for her video series Beta Test. Prior to her career at ... find a new icon in the top right. Tap the chart symbol and the white line shows your 28-day weighted ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

SMITE 2 has entered Open Beta and it's free-to-play for everyone. But how is cross progression going to work for this game?

The iOS 18.3 Release Candidate is now rolling out to developers and public beta testers. The update comes one week after Apple released the third beta, which included major changes to the Apple ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

The Elden Ring Nightreign beta test has been revealed for February 2025 and registrations to potentially be a part of it are now open! During this test, if you've been selected, you'll be able to ...

Greetings, and welcome to BOK Financial Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers ...

janiecbros / Getty Images Smart beta is a way of investing that combines the benefits of passive investing and the advantages of active investing strategies. Smart beta derives from the capital ...

Diamyd Medical has released an updated analysis of the commercial potential for its lead product candidate, the precision immunotherapy Diamyd® (rhGAD65/alum) ...